Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +54.73%
#2 Pons Pons +49.77%
#3 StonkBroker StonkBroker +37.83%
#4 PondCoin PondCoin +37.35%
#5 TENDIES TENDIES +36.53%
#6 Magma Finance Magma Finance +34.48%
#7 Ocean Protocol Ocean Protocol +31.66%
#8 Official Trump Official Trump +27.66%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
#10 Ore Ore +26.90%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Rank in Stocks #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Share Price
$0.07339369
Last synced: 2026-08-18
Market Cap
$25.24M
Change (1 day)
5.26%
Change (1 year)
-9.55%
Country
CA
Trade Resverlogix Corp. (RVX)

Category

Healthcare
Earnings for Resverlogix Corp. (RVX)
Earnings in 2026 TTM: 0
According to Resverlogix Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Resverlogix Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH